Testosterone replacement therapy, also called androgen replacement therapy, is typically used to treat hypogonadism. Testosterone, a hormone produced by the testes, is responsible for the development of secondary sexual characters in men. The levels of testosterone decrease gradually with age, but sometimes this decline is seen even in young men, leading to a condition known as hypogonadism. This can be tareated with external supply of testosterone in the form of gels, patches, injectables, or oral drugs.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Hypogonadism

Understanding Hypergonadism

Pathophysiology

Symptoms

Diagnosis

Treatment

PART 06: Pipeline analysis

TESTAVAN

Vibex QST

LPCN 1021

REXTORO

Enclomiphene

LPCN 1111

TSX-002

TEFINA

THG-1001

MetP Testosterone Nasal Gel

PART 07: Key buying criteria

PART 08: Market landscape

Global endocrinology drugs market

Global testosterone replacement therapy market

Five forces analysis

PART 09: Market segmentation by dosage form

Gels

Injectables

Patches

Others

PART 10: Geographical segmentation

Global testosterone replacement therapy market by

geography 2015-2020

Testosterone replacement therapy market in Americas

Testosterone replacement therapy market in EMEA

Testosterone replacement therapy market in APAC

PART 11: Market drivers

Increase in older population

High incidence of testosterone deficiency

Rise in chronic diseases

Increase in awareness

PART 12: Impact of drivers

PART 13: Market challenges

Generic erosion

FDA warnings on use of testosterone products

Adverse effects

Physicians are reluctant to prescribe medications with

testosterone

Reluctance to discuss condition

PART 14: Impact of drivers and challenges

PART 15: Market trends

Entry of SARMs

Support of patient assistance programs

Focus on emerging markets

Application in new therapeutic indications

PART 16: Vendor landscape

Competitive scenario

Market analysis 2015

AbbVie

Allergan

Eli Lilly

Endo International

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio